Equities Analysts Offer Predictions for PAHC Q3 Earnings

Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) - Analysts at Zacks Research upped their Q3 2025 earnings estimates for shares of Phibro Animal Health in a research report issued to clients and investors on Wednesday, March 12th. Zacks Research analyst R. Department now expects that the company will post earnings per share of $0.50 for the quarter, up from their prior estimate of $0.48. The consensus estimate for Phibro Animal Health's current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health's Q4 2025 earnings at $0.51 EPS, Q2 2026 earnings at $0.56 EPS, Q3 2026 earnings at $0.50 EPS, Q4 2026 earnings at $0.60 EPS, FY2026 earnings at $1.96 EPS, Q2 2027 earnings at $0.56 EPS and FY2027 earnings at $2.21 EPS.

Several other equities research analysts have also recently issued reports on the stock. StockNews.com upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Saturday. Barclays lifted their price objective on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research report on Monday, February 10th. Finally, Morgan Stanley lifted their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a research report on Tuesday, December 17th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat, Phibro Animal Health presently has a consensus rating of "Hold" and a consensus price target of $21.00.

Remove Ads

Phibro Animal Health Price Performance

Shares of Phibro Animal Health stock traded down $0.23 on Friday, hitting $21.62. 148,577 shares of the company traded hands, compared to its average volume of 176,762. The stock has a market capitalization of $875.67 million, a P/E ratio of 45.04, a price-to-earnings-growth ratio of 0.45 and a beta of 0.58. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. Phibro Animal Health has a 52 week low of $12.07 and a 52 week high of $26.55. The business has a 50-day simple moving average of $22.60 and a 200 day simple moving average of $22.59.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%.

Institutional Investors Weigh In On Phibro Animal Health

Large investors have recently bought and sold shares of the business. Geode Capital Management LLC increased its position in Phibro Animal Health by 5.7% in the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company's stock worth $11,430,000 after purchasing an additional 27,201 shares during the last quarter. Barclays PLC boosted its stake in Phibro Animal Health by 25.7% during the third quarter. Barclays PLC now owns 143,337 shares of the company's stock worth $3,228,000 after buying an additional 29,271 shares during the period. Algert Global LLC boosted its stake in Phibro Animal Health by 521.1% during the third quarter. Algert Global LLC now owns 71,335 shares of the company's stock worth $1,606,000 after buying an additional 59,850 shares during the period. FMR LLC boosted its stake in Phibro Animal Health by 22.7% during the third quarter. FMR LLC now owns 39,310 shares of the company's stock worth $885,000 after buying an additional 7,270 shares during the period. Finally, BNP Paribas Financial Markets boosted its stake in Phibro Animal Health by 3.1% during the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company's stock worth $548,000 after buying an additional 729 shares during the period. Institutional investors own 99.34% of the company's stock.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th will be given a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.22%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health's dividend payout ratio is presently 100.00%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.